tirzepatide ban update 🚨 Important on Compounded 🚨, As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable Novo sues Lilly, claiming misleading

Please avoid online compounded GLP-1 medications

doi: 10.1016/j.eprac.2023.02.001 62

Gen Z respondents were most likely to have used a GLP-1 (17%), and millennials were most likely to know someone who had (41%)

On the other hand, the proportion of muscle mass an individual retains is associated with longevity outcomes.(5) To help counteract muscle and bone loss, health professionals can recommend strategies to help maintain bone and muscle mass, such as following a strength training regimen and consuming adequate protein

By booking a complimentary consultation today, you can easily find out if you qualify for our medical weight loss program in Phoenixville PA and what that plan option looks like

Summary: In Phase 2 clinical trials, retatrutide was typically initiated at 2 mg once weekly via subcutaneous injection, with gradual dose escalation over several months under close medical supervision